Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from ING4.
Synthetic
The ING4 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-049140 |
| Réf. fabricant | 18058816 |
| Gene ID (Entrez) | 51147 |
| Espèces | Human |
| Pureté | >95% |
| Numéro d’adhésion | Q9UNL4 |
| Contenu et stockage | Store at -20 C short term. Aliquot and store (at -80 C long term. Avoid freeze-thaw cycles.) |
| Formule | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| À utiliser avec (application) | This product should be used at 1.0μg per 1.0μL of antiserum in per assay. |
| Alias de gène | candidate tumor suppressor p33 ING1 homolog, inhibitor of growth family, member 4, inhibitor of growth protein 4, MGC12557, my036, p29ING4brain my036 protein |
| Symbole de gène(s) | ING4 |
| Type de produit | ING4 Peptide |
| Quantité | 0.05 mg |
| État réglementaire | RUO - research use only |
| Source | Synthetic |
| Consigne | Synthetic peptides corresponding to positions Lin28A: The peptide sequence was selected from the N-terminal region between amino acids 1-60 from Lin28A sequence This sequence is conserved in several other variants of the Lin28A family member |
